Valeant shares plunge

By Staff | November 6, 2015 | Last updated on November 6, 2015
1 min read

Yesterday, shares of Valeant Pharmaceuticals International plunged as much as 20%, building on weeks of losses, reports Reuters.

Reuters adds that these previous losses were mainly due to “concerns about [Valeant’s] ties to specialty pharmacy Philidor Rx Services and its sharp drug price increases,” and those ties have since been cut. Read more.

Also read:

Valeant rebuffs explosive allegations

4 ways to enhance Canadian healthcare

2 ways to invest in U.S. healthcare staff


The staff of have been covering news for financial advisors since 1998.